Oluseye Ogunmoroti
Baptist Hospital of Miami
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Oluseye Ogunmoroti.
Journal of Clinical Lipidology | 2017
Adnan Younus; Choudhry Humayun; Rameez Ahmad; Oluseye Ogunmoroti; Yugandhar Kandimalla; Muhammad Aziz; Rehan Malik; Aisha Rasool Saand; Cyndi Valdes; Rohan Badlani; Muhammad Amir Younus; Shozab S. Ali; Ye Chen; Khurram Nasir
BACKGROUND Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an enzyme that exhibits proinflammatory properties and has been associated with subclinical cardiovascular disease. OBJECTIVE The relationship between Lp-PLA2 and subclinical CVD remains unclear. The goal of this systematic review was to clarify this relationship. METHODS An extensive literature search of the MEDLINE database using Ovid and PubMed was performed. From an initial search of 444 articles, 13 met the inclusion and exclusion criteria and were included in the review. RESULTS Of the 13 studies included in the review, 6 examined the relationship between Lp-PLA2 and coronary artery calcification, of which 3 showed a significant correlation. Two studies examined the relationship between Lp-PLA2 and endothelial dysfunction, and 1 reported a significant relationship. Five studies investigated the association of Lp-PLA2 with carotid intima-media thickness (CIMT), and 3 reported a significant relationship. CONCLUSIONS This review shows a variable association between Lp-PLA2 and subclinical disease. This finding has broad implications for the future of public health and clinical practice. Future research is needed to clarify what role Lp-PLA2 has in guiding treatment and if it is involved in plaque instability, which would make it a useful tool for risk prognostication.
Mayo Clinic Proceedings | 2017
Chukwuemeka U Osondu; Ehimen Aneni; Javier Valero-Elizondo; Joseph A Salami; Maribeth Rouseff; Sankalp Das; Henry Guzman; Adnan Younus; Oluseye Ogunmoroti; Theodore Feldman; Arthur Agatston; Emir Veledar; Barry T. Katzen; Chris Calitz; Eduardo Sanchez; Donald M. Lloyd-Jones; Khurram Nasir
Objective: To examine the association of favorable cardiovascular health (CVH) status with 1‐year health care expenditures and resource utilization in a large health care employee population. Participants and Methods: Employees of Baptist Health South Florida participated in a health risk assessment from January 1 through September 30, 2014. Information on dietary patterns, physical activity, blood pressure, blood glucose level, total cholesterol level, and smoking were collected. Participants were categorized into CVH profiles using the American Heart Associations ideal CVH construct as optimal (6–7 metrics), moderate (3–5 metrics), and low (0–2 metrics). Two‐part econometric models were used to analyze health care expenditures. Results: Of 9097 participants (mean ± SD age, 42.7±12.1 years), 1054 (11.6%) had optimal, 6945 (76.3%) had moderate, and 1098 (12.1%) had low CVH profiles. The mean annual health care expenditures among those with a low CVH profile was
Journal of the American College of Cardiology | 2015
Henry Guzman; Maribeth Rouseff; Thinh Tran; Sankalp Das; Doris Brown; Joann Santiago-Charles; Teresa Ochoa; Joseph Mora; Cynthia Gilliam; Virginia Lehn; Beatriz Castillo; Ehimen Aneni; Emir Veledar; Oluseye Ogunmoroti; Janisse Post; Lara Roberson; Khurram Nasir
10,104 (95% CI,
Progress in Pediatric Cardiology | 2016
Justin M. Pacor; Adnan Younus; Rehan Malik; Chukwuemeka U Osondu; Muhammad Aziz; Oluseye Ogunmoroti; Muhammad Amir Younus; Ehimen Aneni; Erica S. Spatz; Choudhry Humayun; Salim S. Virani; Michael J. Blaha; Khurram Nasir
8633‐
Circulation | 2015
Khurram Nasir; Emir Veledar; Chukwuemeka U Osondu; Ehimen Aneni; Oluseye Ogunmoroti; Sankalp Das; Maribeth Rouseff; Thinh Tran; Don Parris; Leah Holzwarth; Henry Guzman; Theodore Feldman; Michael Ozner; Jonathan Fialkow; Bernie Fernandez; Jack A. Ziffer; Arthur Agatston
11,576) compared with
Circulation-cardiovascular Quality and Outcomes | 2018
Victor Okunrintemi; Joseph A Salami; Javier Valero-Elizondo; Chukwuemeka U Osondu; Oluseye Ogunmoroti; Benjamin Patrick; Timothy M. Pawlik; Khurram Nasir
5824 (95% CI,
Circulation-cardiovascular Quality and Outcomes | 2018
Victor Okunrintemi; Javier Valero-Elizondo; Erin D. Michos; Joseph A Salami; Oluseye Ogunmoroti; Chukwuemeka U Osondu; Martin Tibuakuu; Eve-Marie Benson; Timothy M. Pawlik; Khurram Nasir
5485‐
Circulation-cardiovascular Quality and Outcomes | 2016
Joseph A Salami; Javier Valero-Elizondo; Chuckwuemeka U Osondu; Oluseye Ogunmoroti; Janisse Post; Adnan Younus; Muhammad A. Latif; Rameez Ahmad; Alejandro Arrieta; Erica S. Spatz; Jamal S. Rana; Salim S. Virani; Ron Blanstein; Michael J. Blaha; Emir Veledar; Khurram Nasir
6164) and
Circulation-cardiovascular Quality and Outcomes | 2016
Joseph A Salami; Javier Valero-Elizondo; Oluseye Ogunmoroti; Erica S. Spatz; Jamal S. Rana; Salim S. Virani; Ron Blankstein; Michael J. Blaha; Janisse Post; Alejandro Arrieta; Emir Veledar; Khurram Nasir
4282 (95% CI,
Circulation-cardiovascular Quality and Outcomes | 2016
Javier Valero-Elizondo; Joseph A Salami; Oluseye Ogunmoroti; Shozab S. Ali; Alejandro Arrieta; Erica S. Spatz; Jamal S. Rana; Salim S. Virani; Ron Blankstein; Michael J. Blaha; Emir Veledar; Khurram Nasir
3639‐
